DEX — Dextech Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK130.33m
- SEK116.25m
Annual cashflow statement for Dextech Medical AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.08 | -5.27 | -4.59 | -4.71 | -4.84 |
| Non-Cash Items | 4.13 | 3.03 | 3.06 | 3.69 | 4.21 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.051 | 0.241 | -0.026 | 0.209 | -0.48 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2 | -2 | -1.55 | -0.808 | -1.11 |
| Capital Expenditures | -0.635 | -3.12 | -8.71 | -5.39 | -3.22 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.635 | -3.12 | -8.71 | -5.39 | -3.22 |
| Financing Cash Flow Items | — | -9.22 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 37.1 | 0.026 | 0 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.63 | 32 | -10.2 | -6.19 | -4.33 |